Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations

3-(N-Arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)

(2012) Soo Hyuk Choi et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Molecular Docking and Dynamics Simulation, Receptor-based Hypothesis: Application to Identify Novel Sirtuin 2 Inhibitors

(2012) Sugunadevi Sakkiah et al.   Chemical Biology & Drug Design

Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding

(2012) Sugunadevi Sakkiah et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors

(2010) Jianjun Bao et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Electrochemical and theoretical evaluation of the interaction between dna and amodiaquine: evidence of the guanine adduct formation

(2010) Maria Lara P. M. Arguelho et al.   QUIMICA NOVA

Investigating the ADP-ribosyltransferase Activity of Sirtuins with NAD Analogues and32P-NAD†

(2009) Jintang Du et al.   BIOCHEMISTRY

Conserved Metabolic Regulatory Functions of Sirtuins

(2008) Bjoern Schwer et al.   Cell Metabolism

Structure–Activity Studies on Splitomicin Derivatives as Sirtuin Inhibitors and Computational Prediction of Binding Mode

(2008) Robert C. Neugebauer et al.   JOURNAL OF MEDICINAL CHEMISTRY

Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

(2008) E Lara et al.   ONCOGENE